Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

EXPLAINED: Looking into progyny s return on capital employed | Rare Historical Photos

Pulled from Benzinga Pro data, Progyny (NASDAQ:PGNY) showed a loss in earnings since Q3, totaling $15.08 million. Sales, on the other hand, increased by 4.31% to $127.55 million during Q4. In Q3, Progyny earned $16.80 million and total sales reached $122.28 million.

What Is ROCE?

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.